Kewaunee Scientific Corporation
KEQU
$34.88
$0.320.93%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.17M | 47.76M | 48.39M | 56.70M | 46.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.17M | 47.76M | 48.39M | 56.70M | 46.78M |
| Cost of Revenue | 48.79M | 33.81M | 35.91M | 42.06M | 34.75M |
| Gross Profit | 18.38M | 13.95M | 12.49M | 14.64M | 12.03M |
| SG&A Expenses | 16.13M | 9.52M | 9.91M | 13.14M | 8.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.92M | 43.33M | 45.82M | 55.20M | 43.01M |
| Operating Income | 2.25M | 4.43M | 2.58M | 1.50M | 3.77M |
| Income Before Tax | 1.28M | 3.93M | 2.43M | 1.35M | 3.52M |
| Income Tax Expenses | -108.00K | 916.00K | 192.00K | -9.83M | 982.00K |
| Earnings from Continuing Operations | 1.38M | 3.02M | 2.24M | 11.18M | 2.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.00K | -7.00K | -45.00K | -153.00K | -12.00K |
| Net Income | 1.35M | 3.01M | 2.19M | 11.03M | 2.52M |
| EBIT | 2.25M | 4.43M | 2.58M | 1.50M | 3.77M |
| EBITDA | 3.81M | 5.24M | 3.39M | 2.32M | 4.58M |
| EPS Basic | 0.47 | 1.05 | 0.77 | 3.86 | 0.87 |
| Normalized Basic EPS | 0.27 | 0.85 | 0.52 | 0.24 | 0.76 |
| EPS Diluted | 0.45 | 1.01 | 0.74 | 3.71 | 0.85 |
| Normalized Diluted EPS | 0.26 | 0.82 | 0.50 | 0.23 | 0.74 |
| Average Basic Shares Outstanding | 2.87M | 2.87M | 2.85M | 2.86M | 2.89M |
| Average Diluted Shares Outstanding | 3.00M | 2.97M | 2.97M | 2.97M | 2.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |